Last update 14 Mar 2026

BGM-2121

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
BGM 2121, BGM2121
Target
PTHrP
Action
inhibitors
Mechanism
PTHrP inhibitors(parathyroid hormone like hormone inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Advanced Malignant Solid NeoplasmPancreatic Cancer
Inactive Indication-
Originator Organization
BioGate Precision Medicine Corp.
Active Organization
BioGate Precision Medicine Corp.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Related

1
Clinical Trials associated with BGM-2121
NCT07346846
/ Not yet recruitingPhase 1
A Phase 1 First-in-human Study of BGM-2121 in Patients With Advanced Solid Tumors
100 Clinical Results associated with BGM-2121
Login to view more data
100 Translational Medicine associated with BGM-2121
Login to view more data
100 Patents (Medical) associated with BGM-2121
Login to view more data
100 Deals associated with BGM-2121
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
Taiwan Province
BioGate Precision Medicine Corp.
01 Feb 2026
Pancreatic CancerPreclinical
Taiwan Province
BioGate Precision Medicine Corp.
28 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free